Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation. [electronic resource]
- Investigative ophthalmology & visual science Dec 2000
- 4203-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0146-0404
Administration, Topical Animals Anterior Chamber--immunology Corneal Transplantation--immunology Graft Survival--drug effects Hypersensitivity, Delayed--chemically induced Immune Tolerance--drug effects Immunity Interleukin 1 Receptor Antagonist Protein Male Mice Mice, Inbred BALB C Mice, Inbred C3H Mice, Inbred C57BL Ophthalmic Solutions--therapeutic use Ovalbumin--toxicity Receptors, Interleukin-1--antagonists & inhibitors Recombinant Proteins--therapeutic use Sialoglycoproteins--therapeutic use Transplantation, Homologous